Myasthenia gravis, an autoimmune disease, is a condition that causes weakness of certain muscles, including fluctuating motor weakness of the eye, bulbar, limb, and/or respiratory muscles. Commonly used anti-myasthenia gravis APIs include anticholinesterase inhibitors, glucocorticoids, immunosuppressants, etc. Protheragen offers a full range of anti-myasthenia gravis APIs to support customer research worldwide.